SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1609Well, yeah, to my untutored mind, that's what I thought too. (I don't otom pope-6/23/2006
1608Possibly, their assumption was that use of higher (20 mg) doze for safety databahmpa-6/23/2006
1607When did ya'll learn of the 20mg data being used for 15mg dosing? and why zeta1961-6/23/2006
1606Well said!! I saw Lyons at a bio conference, I think it was spring 05. There wrkrw-6/23/2006
1605although pfizer’s DD and regulatory support to someone who has never dealt with software salesperson-6/23/2006
1604They're piling on - Merrill reiterated its sell this morning.tom pope-6/23/2006
1603now she says sell.... Citi: NBIX: Reduce to Sell; Indiplon Abandoned by PFE Enhamopgcw-6/23/2006
1602And it's trading at 10.30. For once Merrill was right.tom pope-6/22/2006
1601NBIX and PFE part ways. News posted on Biotech Valuation Thread.LJM-6/22/2006
1600Neurocrine and Pfizer Terminate Collaboration Agreement for Indiplon Thursday Judr.praveen-6/22/2006
1599Merrill: Neurocrine still not cheap despite sell-off On 16 June, NBIX’s stock tom pope-6/19/2006
1598I was hoping to get in also but will wait a few weeks before buying.Eugene E. Dorsey-6/19/2006
1597Neurocrine Shares Slide On Likely Indiplon Delay By Aaron Lorenzo Washington EdiIcebrg-6/18/2006
1596At some point the other assets have to provide a floor. I am tempted at this prRocky9-6/16/2006
1595catching falling knives, has given me a few scabs before, but this one hurts. wmopgcw-6/16/2006
1594Neurocrine: May Need Sleeping Pill Tests Thursday June 15, 7:05 pm ET By TheresLJM-6/15/2006
1593No Rest Yet for Neurocrine By Robert Steyer TheStreet.com Staff Reporter 6/15/LJM-6/15/2006
1592Neurocrine Completes Review of Indiplon Action Letters June 15, 2006 16:44:29 LJM-6/15/2006
1591Barbara Ryan is one of the better pharma analysts, IMO.DewDiligence_on_SI-6/12/2006
1590bweek: Going From The Lab To Limbo The FDA has been delaying decisions on applimopgcw-6/12/2006
1589BGlobe: The big sleep Pfizer pushes into the multibillion-dollarmarket to treat mopgcw-6/12/2006
1588bio k, that view has been reflected in discussion on this or the Valuation threaquidditch-5/23/2006
1587I know this is a bit late but I've been thinking about this not approvable abio_kruncher-5/23/2006
1586WASHINGTON, DC, United States (UPI) -- Analysts downgraded Neurocrine after its Icebrg-5/19/2006
1585He must be millions into margin to have to sell $2.3M to climb out! Sad but reckrkrw-5/18/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News